Clinical Trials Directory

Trials / Completed

CompletedNCT01049321

The Effect of DASH Diet on the Cardiometabolic Risks and Hepatic Function Among Type 2 Diabetic Patients

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
36 (actual)
Sponsor
Isfahan University of Medical Sciences · Academic / Other
Sex
All
Age
44 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The investigators are not aware of any study regarding the effect of DASH eating pattern on different cardiovascular risks among type 2 diabetic patients. The investigators assumed that DASH eating pattern could reduce the cardio-metabolic risks and improve the hepatic function among type 2 diabetes.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTDASH diet
DIETARY_SUPPLEMENTa usual diabetic diet

Timeline

Start date
2008-12-01
Primary completion
2009-06-01
Completion
2009-12-01
First posted
2010-01-14
Last updated
2010-01-14

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT01049321. Inclusion in this directory is not an endorsement.

The Effect of DASH Diet on the Cardiometabolic Risks and Hepatic Function Among Type 2 Diabetic Patients (NCT01049321) · Clinical Trials Directory